Sanofi

Olympic Sponsor Sanofi Makes Major Play In Rare Disease Arena $2.2 Billion Acquisition Of Inhibrx Project

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran

Fintech Focus For July 3, 2020

Regeneron Pharmaceuticals Gains A Bull Ahead Of Earnings

Fintech Focus For July 3, 2020

Regeneron Pharmaceuticals Gains A Bull Ahead Of Earnings

Expectations For Regeneron No Longer Realistic; Analyst Downgrades

Sanofi Names Candidates, Committed To Replacing Medivation's Entire Board

Sanofi Recent News

Here's What Medivation Said In Its Rejection Letter To Sanofi

Sanofi Wants To Acquire Medivation For $52.50 Per Share

Big Biotech In The Earnings Spotlight

Sanofi Shares Rise After Company Agrees To Sell Nichi-Iko Pharma Stake

Sanofi Is Looking For Rare Disease Acquisitions, FT Says

EXCLUSIVE: Sanofi In Talks To Buy PTC Therapeutics

Sanofi's Stock Dips Lower Following Q4 Print

Regeneron, Sanofi Announce FDA Has Accepted For Review BLA For Sarilumab

MannKind Is Plummeting

Regeneron Shares Rising After Sanofi Collaboration Revealed: Good News For Shareholders?

MannKind 'Facing Low Profitability And Delayed Profits' As Afrezza Ramp Fizzles, Goldman Says

Piper Jaffray Dishes On MannKind's Afrezza Data

Regeneron Earnings: Small Growth Expected, Driven By Eylea

What's Afrezza's Ultimate Potential For MannKind?

Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger

These 2 Dodge & Cox Funds Are Big Hewlett-Packard Owners

Dow, S&P 500 Close At Record Highs In Another Quiet Trading Session

Perrigo Surges Amid Report Of Omega Pharma Acquisition

QE Finally Ends

Markets Continue To Rally As The Dow Closes Above 17,000

Markets Rally On Fed Minutes, Alcoa Kicks Off Earnings Season With Strong Beat

Unilife Corp Shares Continue To Rise Following Sanofi Deal

Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments